Loss of ciprofloxacin's second killing action in Escherichia coli that have developed 4-quinolone resistance during therapy.
Lewin
C S
CS
Blakemore
P
P
Drabu
Y J
YJ
Smith
J T
JT
D002701:Chloramphenicol / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects*; D009268:Nalidixic Acid / Q000494:pharmacology
D009268:Nalidixic Acid; D002939:Ciprofloxacin; D002701:Chloramphenicol